Description
The global Immunoprotein Diagnostic Testing market value was USD 11,136.40 million in 2021and; it is estimated to reach USD 19,387.19 million by 2028, with a CAGR of 7.2%from 2022 to 2028. An increase in the prevalence of chronic diseases has conducted to the growth of the immunoprotein diagnostic testing market. The expanded prevalence of chronic disorders, such as infectious conditions, cancer, cardiovascular disease, obesity, type 2 diabetes, and rheumatoid arthritis, has led to the growth of immunoprotein diagnostic testing products. Growing mortality due to such chronic diseases has led to an urgent demand for rapid diagnosis.
What is Immunoprotein Diagnostics Testing?
Immunoproteins are proteins like immunoglobulin, haptoglobin, and pre-albumin located in the blood and regulate the body’s immune responses. The testing of immunoproteins seeks to diagnose health conditions revealed by abnormal immunoprotein activity. The need within the global market for immunoprotein diagnostic testing has achieved momentum on account of key consequences in the field of medical treatment and diagnostics. Immunoproteins, in essence, refer to blood proteins that play an essential role in the functioning of the immune system.
